Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,747,030,778
-$179,115,440 QoQ
Shares Held
13,828,010
+0.1% QoQ
Ownership
1.12%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#17
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $34,817,743,578 across 17 Drug Manufacturers - General names. GILD ranks #6 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,796,866 | $10,551,225,859 | |
| 2 | JNJ |
Johnson & Johnson
|
28,792,064 | $7,312,320,489 | |
| 3 | ABBV |
AbbVie Inc.
|
20,558,447 | $5,173,327,597 | |
| 4 | MRK |
Merck & Co., Inc.
|
26,275,718 | $3,376,429,761 | |
| 5 | AMGN |
Amgen Inc
|
6,200,994 | $2,245,503,942 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
13,828,010 | $1,747,030,778 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
24,918,384 | $1,435,797,281 | |
| 8 | PFE |
Pfizer Inc
|
59,084,573 | $1,422,756,513 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,747,030,778 | 13,828,010 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $1,926,146,218 | 13,820,379 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,725,473,514 | 14,057,956 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,589,148,816 | 14,316,656 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,597,561,637 | 14,409,323 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,617,596,597 | 14,436,382 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,377,707,320 | 14,915,095 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,044,322,859 | 12,456,141 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $889,882,950 | 12,970,164 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $969,043,879 | 13,229,268 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,136,237,995 | 14,025,898 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,118,291,249 | 14,922,488 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,111,196,260 | 14,418,013 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,207,199,062 | 14,549,826 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,282,813,278 | 14,942,496 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $943,956,812 | 15,301,618 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $946,506,974 | 15,313,169 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $889,921,969 | 14,969,251 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,055,636,199 | 14,538,441 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,011,285,922 | 14,477,966 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,038,469,670 | 15,080,884 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $977,796,705 | 15,129,146 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $888,105,475 | 15,243,829 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,001,755,238 | 15,853,066 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,237,287,987 | 16,081,206 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $1,162,886,042 | 15,554,923 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||